Skip to Main Content

Paper Details

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer.
Oncogene
5
2023
Author NameAffiliation
Martin E Gleave
Martin E GleaveUniversity of British Columbia
Eva CoreyUniversity of Washington
Primo N LaraUC Davis Comprehensive Cancer Center, University of California Davis
Primo N LaraUniversity of California Davis
Christopher P EvansUniversity of California Davis
Christopher P EvansUC Davis Comprehensive Cancer Center, University of California Davis
  • 1 - 7

Datasets

Release 1.2